standard

FDA–SEC Memorandum of Understanding (2026)

Three-year interagency agreement between the FDA and the SEC setting procedures for exchanging nonpublic information about FDA-regulated products, activities and companies, including referrals and designated contacts.

Known aliases

FDA-SEC MOU
the MOU

Relationships

No evidence-backed relationships are recorded.

Current clusters

leadership1 publisher

A three-year FDA pact opens the agency's nonpublic file to SEC reviewers

Securities staff now have an agreed route to the FDA's nonpublic record of a company's regulatory interactions and inspections. They can use it during a routine filing review, before any investigation is open.

Publishers:corpgov.law.harvard.edu

Reality

Evidence58
Adoption: Insufficient
Hype gap+5
Incentives65
Confidence50